POST Online Media Lite Edition


Toshiba starts collecting genome data in Japan

Christian Fernsby |
Toshiba promotes two major initiatives: the use of Japonica Array to build a genome database; and a partnership with a venture capital company, entered into today, to promote investments in medical start-ups and business collaborations.

Article continues below

Japonica Array is a genome sequencer that, in its present form, is configured to analyze genomic base sequence variations common in the DNA of Japanese, making it possible to genotype Japanese people in a short time.

By building up tens of thousands of genomic data and health data drawn from volunteers in its corporate group, Toshiba will work with medical and life science organizations and researchers to secure advances in preventative medicine that contribute to predicting diseases and specific traits and predispositions; preventing lifestyle diseases; and to curtailing the advance of diseases and limiting their severity.

In parallel with this, Toshiba will also channel funds into promoting cultivation of new medical businesses.

The Toshiba Next Plan introduced an in-house Corporate Venture Capital fund (CVC) with some 10-billion yen in capital, and a mandate to create new businesses.

Toshiba will partner with Beyond Next Ventures Inc., a Japanese business accelerator with track record of investment in medical start-ups, to identify promising venture companies and areas for collaboration.

What to read next

Canadian housing starts trend decreases in September
Toshiba has tablet and it's cool
U.S. judge postpones decision in bid to block Toshiba memory unit sale